CMS has posted the July 2009 Medicare Part B drug average sales price (ASP) files.  CMS notes that prices generally have been stable, with prices for the top part B drugs increasing by less than one percent over the previous quarter, and most of the higher-volume drugs (30 out of the top 50), changing 2 percent or less.